PRVA Valuation

Privia Health Group Inc

Add to Watchlist

Advanced Chart

23.740

+1.19(5.277%)1D

PRVA Relative Valuation

PRVA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PRVA is overvalued; if below, it's undervalued.

Historical Valuation

Privia Health Group Inc (PRVA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 46.69. The fair price of Privia Health Group Inc (PRVA) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：23.74

Fair

91.84

Trailing

Forward

18.40

EV/EBITDA

Privia Health Group Inc. (PRVA) has a current EV/EBITDA of 18.40. The 5-year average EV/EBITDA is 37.21. The thresholds are as follows: Strongly Undervalued below -4.68, Undervalued between -4.68 and 16.26, Fairly Valued between 58.15 and 16.26, Overvalued between 58.15 and 79.10, and Strongly Overvalued above 79.10. The current Forward EV/EBITDA of 18.40 falls within the Historic Trend Line -Fairly Valued range.

58.43

EV/EBIT

Privia Health Group Inc. (PRVA) has a current EV/EBIT of 58.43. The 5-year average EV/EBIT is 1111.98. The thresholds are as follows: Strongly Undervalued below -7599.11, Undervalued between -7599.11 and -3243.57, Fairly Valued between 5467.52 and -3243.57, Overvalued between 5467.52 and 9823.07, and Strongly Overvalued above 9823.07. The current Forward EV/EBIT of 58.43 falls within the Historic Trend Line -Fairly Valued range.

1.24

Privia Health Group Inc. (PRVA) has a current PS of 1.24. The 5-year average PS is 1.96. The thresholds are as follows: Strongly Undervalued below 0.18, Undervalued between 0.18 and 1.07, Fairly Valued between 2.85 and 1.07, Overvalued between 2.85 and 3.74, and Strongly Overvalued above 3.74. The current Forward PS of 1.24 falls within the Historic Trend Line -Fairly Valued range.

23.43

P/OCF

Privia Health Group Inc. (PRVA) has a current P/OCF of 23.43. The 5-year average P/OCF is 45.47. The thresholds are as follows: Strongly Undervalued below 4.19, Undervalued between 4.19 and 24.83, Fairly Valued between 66.11 and 24.83, Overvalued between 66.11 and 86.74, and Strongly Overvalued above 86.74. The current Forward P/OCF of 23.43 falls within the Undervalued range.

23.02

P/FCF

Privia Health Group Inc. (PRVA) has a current P/FCF of 23.02. The 5-year average P/FCF is 45.46. The thresholds are as follows: Strongly Undervalued below 4.39, Undervalued between 4.39 and 24.92, Fairly Valued between 65.99 and 24.92, Overvalued between 65.99 and 86.53, and Strongly Overvalued above 86.53. The current Forward P/FCF of 23.02 falls within the Undervalued range.

Privia Health Group Inc (PRVA) has a current Price-to-Book (P/B) ratio of 4.11. Compared to its 3-year average P/B ratio of 4.64 , the current P/B ratio is approximately -11.44% higher. Relative to its 5-year average P/B ratio of 6.22, the current P/B ratio is about -33.84% higher. Privia Health Group Inc (PRVA) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 2.79%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 2.35% , the current FCF yield is about -100.00% lower.

4.11

P/B

Median3y

4.64

Median5y

6.22

3.99

FCF Yield

Median3y

2.79

Median5y

2.35

Competitors Valuation Multiple

The average P/S ratio for PRVA's competitors is , providing a benchmark for relative valuation. Privia Health Group Inc Corp (PRVA) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 32.54%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

PRVA.O

Privia Health Group Inc

Brighthouse Financial Inc

Clover Health Investments Corp

Jackson Financial Inc

Loss

-34.58%

6.38B

Performance Decomposition

Market capitalization of PRVA increased by 10.52% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 0.91 to 1.69.

The secondary factor is the Revenue Growth, contributed 32.54%to the performance.

Overall, the performance of PRVA in the past 1 year is driven by Margin Expansion. Which is more sustainable.

32.54%

437.92M → 580.42M

Revenue Growth

85.71%

0.91 → 1.69

Margin Expansion

-107.73%

-2.19K → 169.48

P/E Change

10.52%